Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Procter & Gamble Hygiene and Health Care (BOM:500459) Receivables Turnover Explanation
An efficient company has a higher accounts receivable turnover ratio while an inefficient company has a lower ratio. This metric is commonly used to compare companies within the same industry to check whether they are on par with their competitors.
Procter & Gamble Hygiene and Health Care Receivables Turnover Related Terms
Procter & Gamble Hygiene and Health Care Receivables Turnover Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Procter & Gamble Hygiene and Health Care Receivables Turnover Chart
Procter & Gamble Hygiene and Health Care Annual Data
BOM:500459 vs PG, CL, KVUE: Receivables Turnover Comparison
For the Household & Personal Products subindustry, Procter & Gamble Hygiene and Health Care's Receivables Turnover, along with its competitors' market caps and Receivables Turnover data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Procter & Gamble Hygiene and Health Care Receivables Turnover vs Consumer Packaged Goods Industry
For the Consumer Packaged Goods industry and Consumer Defensive sector, Procter & Gamble Hygiene and Health Care's Receivables Turnover distribution charts can be found below:
* The bar in red indicates where Procter & Gamble Hygiene and Health Care's Receivables Turnover falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Procter & Gamble Hygiene and Health Care (BOM:500459) has a Receivables Turnover of 3.67 as of Jun. 2026. The accounts receivables turnover ratio measures the number of times a company collects its average accounts receivable balance. It is calculated as Revenue divided by Average Accounts Receivable. View historical data on Procter & Gamble Hygiene and Health Care and its competitors. According to the industry distribution chart, Procter & Gamble Hygiene and Health Care ranks #598 out of 1948 companies in the Consumer Packaged Goods industry, placing it in the top 30.7%.
Is Procter & Gamble Hygiene and Health Care's Receivables Turnover too high?
Procter & Gamble Hygiene and Health Care's current Receivables Turnover is 3.67. The Consumer Packaged Goods industry median Receivables Turnover is 9.42. Procter & Gamble Hygiene and Health Care's value of 3.67 is 61% below this industry median. Based on the distribution chart, Procter & Gamble Hygiene and Health Care ranks #598 out of 1948 companies in the Consumer Packaged Goods industry, which is above the industry midpoint. Overall, Procter & Gamble Hygiene and Health Care has a GF Score™ of 76/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Procter & Gamble Hygiene and Health Care's Receivables Turnover compare to PG and CL?
According to the Consumer Packaged Goods industry distribution chart, Procter & Gamble Hygiene and Health Care ranks #598 out of 1948 companies for Receivables Turnover. This puts Procter & Gamble Hygiene and Health Care in the upper half of its industry. The industry median Receivables Turnover is 9.42. Procter & Gamble Hygiene and Health Care's value of 3.67 is 61% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Receivables Turnover for a Consumer Packaged Goods company?
The median Receivables Turnover among Consumer Packaged Goods companies is 9.42, based on 1,948 companies in the industry. Companies in the top quartile (top 25%) have a Receivables Turnover significantly above this median, while those in the bottom quartile fall well below. However, Receivables Turnover should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Procter & Gamble Hygiene and Health Care's current Receivables Turnover of 3.67 is 61% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Receivables Turnover mean?
A high Receivables Turnover can signal that a stock is expensive relative to its fundamentals. The accounts receivables turnover ratio measures the number of times a company collects its average accounts receivable balance. It is calculated as Revenue divided by Average Accounts Receivable. View historical data on Procter & Gamble Hygiene and Health Care and its competitors. For the Consumer Packaged Goods industry, the median Receivables Turnover is 9.42 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Procter & Gamble Hygiene and Health Care's current Receivables Turnover is 3.67. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Procter & Gamble Hygiene and Health Care stock overvalued right now?
Based on GuruFocus' analysis, Procter & Gamble Hygiene and Health Care (BOM:500459) is currently considered Significantly Undervalued. The stock's GF Value™ is ₹14,267.26, compared to a current price of ₹8,095.90 — trading 43.3% below its estimated fair value. The current Receivables Turnover is 3.67 and 61% below the Consumer Packaged Goods industry median of 9.42. Procter & Gamble Hygiene and Health Care's overall GF Score™ is 76/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Receivables Turnover calculated?
Receivables Turnover is calculated from a company's financial statements. For Procter & Gamble Hygiene and Health Care (BOM:500459), the current Receivables Turnover is 3.67 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Procter & Gamble Hygiene and Health Care (BOM:500459) Overvalued in 2026?
Based on GuruFocus' analysis, Procter & Gamble Hygiene and Health Care stock appears to be undervalued.
The current stock price of ₹8,095.90 is trading 43.3% below its estimated GF Value™ of ₹14,267.26.
GuruFocus considers Procter & Gamble Hygiene and Health Care to be Significantly Undervalued.
Key valuation signals for BOM:500459:
Receivables Turnover: 3.67
GF Value™: ₹14,267.26 vs. price of ₹8,095.90 (43.3% below fair value)
Industry Position: 61% below the Consumer Packaged Goods median (#598 of 1948)
No single metric tells the full story. See the BOM:500459 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Procter & Gamble Hygiene and Health Care Ltd is an Indian company engaged in the manufacturing and selling of feminine hygiene care and healthcare products. The portfolio includes brands like Ambi Pur, Head & Shoulders, Olay, Oral-B, Pampers, Pantene, Tide Ariel, Duracell, Gillette, Vicks, and Wella. The business is divided into a feminine hygiene business and a healthcare business. The feminine hygiene business offers sanitary napkins and feminine sanitary hygiene products; its popular brand is Whisper. The healthcare business offers creams, cough drops, and other health products. The company distributes its products through various channels: from retail locations such as mass merchandizers and grocery stores, to drug stores and department stores.
76GF Score
Get the complete analysis for BOM:500459
Receivables Turnover is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BOM:500459 has been successfully added to your 
